Literature DB >> 30219747

Genetic diversity of Hepatitis C Virus in Pakistan using Next Generation Sequencing.

Sana Saleem1, Amjad Ali2, Bushra Khubaib3, Madiha Akram4, Zareen Fatima5, Muhammad Idrees6.   

Abstract

BACKGROUND: In Pakistan, HCV disease is considered a major public health issue with about 10-17 million people suffering with this infection and rate is increasing every day without any hindrance. The currently available Pyrosequencing approach used to analyze complex viral genomes as it can determine minor variants. It is crucial to understand viral evolution and quasispecies diversity in complex viral strains.
OBJECTIVES: To assess genetic diversity in patients with HCV using Next Generation Sequencing (NGS) and compare nucleotide diversity of genotype 3a with respect to other genotypes. STUDY
DESIGN: Intra-host viral diversity of HCV was determined using NGS from 13 chronically HCV infected individuals. NGS of three different regions (E2 (HVR1), NS3 and NS5B) of HCV-3a allowed for a comprehensive analysis of the viral population. RESULT: Phylogenetic analysis of different HCV genes revealed great variability within the Pakistani population. The average nucleotide diversity for HVR1, NS3 and NS5B was 0.029, 0.011 and 0.010 respectively.
CONCLUSION: Our findings clearly indicate that patient-2 greater quasispecies heterogeneity than other patients of same genotype-3a using phylogenetic and one step network analyses. Initially phylogenetic analysis of these three genes showed that genotype 3a samples have greater genetic diversity. However, no significant difference was determined when nucleotide variability of genotype 3a compared with other genotypes (1a, 1b, 2a & 4a).
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3a; Analysis; HCV; HVR1; NGS; NS3; NS5B; Phylogentic; Quasispecies

Mesh:

Year:  2018        PMID: 30219747     DOI: 10.1016/j.jcv.2018.09.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  2 in total

1.  New drugs and new concerns: Gaining insight through Pharmacovigilance of direct acting Anti-Viral's in chronic HCV patients.

Authors:  Zahid Yasin Hashmi; Muhammad Qasim Zia; Akram Bajwa; Maqsood Ahmed; Naveed Anwer; Mahwish Raza; Jaffer Bin Baqar
Journal:  Pak J Med Sci       Date:  2021 Mar-Apr       Impact factor: 1.088

2.  Porcine circovirus 2 (PCV2) population study in experimentally infected pigs developing PCV2-systemic disease or a subclinical infection.

Authors:  Florencia Correa-Fiz; Giovanni Franzo; Anna Llorens; Eva Huerta; Marina Sibila; Tuija Kekarainen; Joaquim Segalés
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.